摘要 |
<p>Abstract Polymorphs of chemical compounds that modulate kinase activity, including P13 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associates with kinase activity, including PI 3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof. V) u 5000 10 20 30 40 Position [02 Theta] (Copper (Cu)) Polymorph Form A Fig. 1</p> |
申请人 |
INFINITY PHARMACEUTICALS INC. |
发明人 |
REN, PINGDA;MARTIN, MICHAEL;ISBESTER, PAUL;LANE, BENJAMIN S.;KROPP, JASON |